tiprankstipranks
Trending News
More News >
PFIZER LIMITED (IN:PFIZER)
:PFIZER
India Market

PFIZER LIMITED (PFIZER) Price & Analysis

Compare
109 Followers

PFIZER Stock Chart & Stats

₹4887.30
₹34.05(0.64%)
At close: 4:00 PM EST
₹4887.30
₹34.05(0.64%)

Bulls Say, Bears Say

Bulls Say
Balance Sheet HealthExtremely low leverage and a high equity ratio provide durable financial flexibility, enabling sustained R&D investment, dividend support, and M&A optionality. A strong ROE indicates efficient capital use, which helps the business withstand industry cycles and fund long-term strategic initiatives.
Cash GenerationVery strong free cash flow conversion and large FCF growth underpin sustainable funding for pipelines, capital allocation, and shareholder returns. Reliable cash conversion reduces refinancing risk and supports durable operating plans even if topline growth slows.
High Profitability/MarginsConsistently high gross and operating margins indicate durable pricing power and operational efficiency. Strong profitability provides buffer versus pricing pressure, funds reinvestment in product development, and sustains long-term returns even in competitive pharmaceutical markets.
Bears Say
Revenue VolatilityVolatile top-line performance reduces predictability of future cash flows and makes long-term planning harder for a product-driven pharma business. It can reflect portfolio concentration, timing of product cycles, or one-off items that impair steady organic growth over multiple quarters.
Limited Entity DisclosureLack of clear disclosure about the legal entity's exact operating scope complicates assessment of revenue drivers, regulatory exposures, and operational risks. This structural opacity can hinder investor understanding of sustainable cash flows and long-term strategy execution.
Moderate Top-line GrowthSingle-digit revenue growth suggests limited organic expansion relative to high-margin profile, necessitating continued reliance on margin improvements or cash deployment to drive returns. Sustained low growth could pressure long-term EPS upside absent major product launches or acquisitions.

PFIZER FAQ

What was PFIZER LIMITED’s price range in the past 12 months?
PFIZER LIMITED lowest stock price was ₹3742.90 and its highest was ₹5987.65 in the past 12 months.
    What is PFIZER LIMITED’s market cap?
    PFIZER LIMITED’s market cap is ₹235.59B.
      When is PFIZER LIMITED’s upcoming earnings report date?
      PFIZER LIMITED’s upcoming earnings report date is Jun 03, 2026 which is in 99 days.
        How were PFIZER LIMITED’s earnings last quarter?
        PFIZER LIMITED released its earnings results on Feb 09, 2026. The company reported ₹40.4 earnings per share for the quarter, beating the consensus estimate of ₹36.6 by ₹3.8.
          Is PFIZER LIMITED overvalued?
          According to Wall Street analysts PFIZER LIMITED’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does PFIZER LIMITED pay dividends?
            PFIZER LIMITED pays a Notavailable dividend of ₹165 which represents an annual dividend yield of 0.69%. See more information on PFIZER LIMITED dividends here
              What is PFIZER LIMITED’s EPS estimate?
              PFIZER LIMITED’s EPS estimate is 45.
                How many shares outstanding does PFIZER LIMITED have?
                PFIZER LIMITED has 45,747,730 shares outstanding.
                  What happened to PFIZER LIMITED’s price movement after its last earnings report?
                  PFIZER LIMITED reported an EPS of ₹40.4 in its last earnings report, beating expectations of ₹36.6. Following the earnings report the stock price went up 3.621%.
                    Which hedge fund is a major shareholder of PFIZER LIMITED?
                    Currently, no hedge funds are holding shares in IN:PFIZER
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      PFIZER LIMITED

                      Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India.

                      PFIZER LIMITED (PFIZER) Earnings & Revenues

                      PFIZER Stock 12 Month Forecast

                      Average Price Target

                      ₹6,030.00
                      ▲(23.38% Upside)
                      {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3922":"₹3,922","6031":"₹6,031","4449.25":"₹4,449.3","4976.5":"₹4,976.5","5503.75":"₹5,503.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6030,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹6K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6030,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹6K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6030,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹6K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3922,4449.25,4976.5,5503.75,6031],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Sep<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4566.15,4678.753846153846,4791.357692307692,4903.961538461538,5016.565384615385,5129.16923076923,5241.773076923077,5354.376923076923,5466.9807692307695,5579.584615384615,5692.1884615384615,5804.792307692307,5917.3961538461535,{"y":6030,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4566.15,4678.753846153846,4791.357692307692,4903.961538461538,5016.565384615385,5129.16923076923,5241.773076923077,5354.376923076923,5466.9807692307695,5579.584615384615,5692.1884615384615,5804.792307692307,5917.3961538461535,{"y":6030,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4566.15,4678.753846153846,4791.357692307692,4903.961538461538,5016.565384615385,5129.16923076923,5241.773076923077,5354.376923076923,5466.9807692307695,5579.584615384615,5692.1884615384615,5804.792307692307,5917.3961538461535,{"y":6030,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5149.96,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4408.14,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3937.54,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3923.02,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4176.66,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5460.99,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5538.25,"date":1751328000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5538.25,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5050.7,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5136.4,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5150.6,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4918.7,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4566.15,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Alkem Laboratories Ltd.
                      AstraZeneca Pharma India Limited
                      Glenmark Pharmaceuticals Limited
                      IPCA Laboratories Limited
                      Popular Stocks